Table 2 Comparison of LDLT patients and surgery characteristics according to four group
|  | Non-HAD and high SMI group (n = 58) | Non-HAD and Low SMI group (n = 31) | HAD and high SMI group (n = 34) | HAD and low SMI group (n = 12) | p-value |
|---|---|---|---|---|---|
Gender, male, n (%) | 33 (57.0) | 15 (48.4) | 18 (52.9) | 7 (58.3) | 0.874 |
Age, year | 57.0 (52.0–63.0) | 57.0 (50.0–61.0) | 57.0 (52.0–65.0) | 56.0 (46.3–63.3) | 0.695 |
BMI, kg/m2 | 20.4 (17.7–23.4) | 18.9 (15.8–21.0) | 19.9 (17.7–22.1) | 19.6 (16.2–22.0) | 0.087 |
GNRI, points | 83.8 (75.5–92.2) | 78.7 (69.7–85.8) | 84.3 (73.6–91.5) | 80.7 (75.2–89.1) | 0.392 |
  < 92 | 43 (74.1) | 25 (80.7) | 27 (79.4) | 10 (83.3) | 0.835 |
 ≥ 92 | 15 (25.9) | 6 (19.4) | 7 (20.6) | 2 (16.7) |  |
Type of disease, n (%) | |||||
 Primary biliary cirrhosis | 4 (6.9) | 1 (3.2) | 6 (17.7) | 0 | 0.074 |
 Primary sclerosing cholangitis | 2 (3.5) | 2 (6.5) | 1 (2.9) | 2 (16.7) |  |
 Hepatitis B Virus | 8 (13.8) | 3 (9.7) | 4 (11.8) | 0 |  |
 Hepatitis C virus | 21 (36.2) | 12 (38.7) | 12 (35.3) | 6 (50.0) |  |
 Non-B, non-C liver cirrhosis | 6 (10.3) | 2 (6.5) | 4 (11.8) | 1 (8.3) |  |
 Other | 17 (29.3) | 11 (35.5) | 7 (21.0) | 3 (25.0) |  |
Comorbidity, n (%) | |||||
 Hepatocellular carcinoma | 25 (43.1) | 10 (32.3) | 14 (41.8) | 5 (41.7) | 0.792 |
MELD score | 17.0 (11.0–21.3) | 17.0 (12.0–18.0) | 15.0 (12.0–18.3) | 17.0 (13.0–23.0) | 0.796 |
Operation time, min | 752.0 (702.5–829.3) | 739.0 (686.0–803.0) | 780.5 (706.0–904.0) | 849.0 (751.3–962.0) | 0.064 |
Operative blood loss, g | 5225 (3463–8627) | 4900 (3700–8900) | 6300 (2899–12,337) | 7848 (4900–13,292.5) | 0.248 |
Donor age, year | 31.5 (26.8–40.3) | 36.0 (30.0–53.0) | 33.0 (25.5–40.3) | 34.0 (29.0–45.8) | 0.504 |
Left lobe graft, n (%) | 36 (62.1) | 21 (67.7) | 22 (64.7) | 8 (66.7) | 0.642 |
GW/SLV, % | 39.7 (33.7–51.6) | 42.5 (33.0–52.9) | 40.2 (33.5–44.4) | 37.8 (33.7–45.3) | 0.626 |
ABO-incompatible, n (%) | 11 (19.0) | 11 (35.5) | 7 (20.1) | 1 (8.3) | 0.029 |
SMI, cm2/m2 | |||||
 Male, n (%) | 47.8 (44.1–55.4) | 35.5 (30.7–39.3) | 46.6 (43.8–49.6) | 37.6 (35.6–41.2) |  < 0.001 |
 Female, n (%) | 46.7 (43.2–48.9) | 33.4 (28.9–36.1) | 43.0 (39.9–49.5) | 34.5 (32.4–37.1) |  < 0.001 |
Initial walking, day | 8.0 (5.0–11.3) | 11.0 (7.0–15.0) | 13.0 (6.8–19.3) | 11.5 (6.3–41.3) | 0.052 |
ICU length of stay, days | 5.0 (3.8–7.3) | 5.0 (4.0–8.0) | 5.5 (4.0–9.0) | 5.5 (5.0–15.8) | 0.237 |
BI at admission, points | 100 (80–100) | 100 (65–100) | 100 (95–100) | 100 (100–100) | 0.119 |
BI at hospital discharge, points | 100 (100–100) | 100 (100–100) | 90 (70–95) | 90 (85–95) |  < 0.001 |
Hospital length of stay, days | 42.0 (33.0–52.3) | 52.0 (37.0–76.0) | 58.0 (46.8–74.5) | 58.0 (39.3–99.5) |  < 0.001 |
Transfer to hospital, n (%) | 5 (8.6) | 6 (19.4) | 14 (42.4) | 4 (33.3) |  < 0.01 |